metronidazole and tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Switch to Tirzepatide in T2D

Semaglutide + phentermine : Phentermine is oral and dosed in milligrams

GLP-1 receptor agonists enhance glucose-dependent insulin secretion and promote satiety, whilst SGLT2 inhibitors block renal glucose reabsorption causing urinary glucose excretion

doi: 10.1002/hep.24376

Hyperleptinemia, characterized by elevated leptin levels, is commonly observed in individuals who are obese or overweight

Gastrointestinal adverse events were observed with tirzepatide, though discontinuation rates were low (2.9% vs 0.8% with ixekizumab alone)

Though these risks are rare, they are important to keep in mind, especially when dealing with a population already battling cancer